Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × pralsetinib × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1 NET 1 Head & Neck 1 Gastrointestinal 1 Endocrine 1

Conditions

Interventions

Nivolumab 3 Ipilimumab 3 pembrolizumab 2 entrectinib 2 cobimetinib 2 Pemetrexed 2 Cisplatin 2 tovorafenib 1 sotorasib 1 relatlimab 1 pralsetinib 1 larotrectinib 1 ipatasertib 1 inavolisib 1 daratumumab 1 atezolizumab 1 alectinib 1 PM 01183 1 Midazolam 1 Carboplatin 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04589845 2026-03-06

Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study

Hoffmann-La Roche

Phase 2 Recruiting

920 enrolled 1 FDA

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡